The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation

Genes and Development

Volumn 12, Issue 14, 1998, Pages 2153-2163

  Feng, Xin Hua ^a   Zhang, Ying ^a   Wu, Rui Yun ^a   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CBP p300; PAI 1 promoter; Smad; TGF signaling; Transcription

Indexed keywords

ADAPTOR PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA BINDING PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; NUCLEOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS1; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION;

ANIMALIA;

EID: 0032528236     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.14.2153     Document Type: Article

References (41)

1. 467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272: 27678-27685.
2. Avantaggiati, M.L., V. Ogryzko, K. Gardner, A. Giordano, A. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184.
3. Candia, A., T. Watabe, S. Hawley, D. Onichtchouk, Y. Zhang, R. Derynck, C. Niehrs, and K.W.Y. Cho. 1997. Cellular interpretation of multiple TGF-β signals: Intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 124: 4467-4480.
4. Chen, F. and R.A. Weinberg. 1995. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc. Natl. Acad. Sci. 92: 1565-1569.
5. Chen, X., E. Weisberg, V. Fridmacher, M. Watanabe, G. Naco, and M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89.
6. Datto, M., Y. Li, J. Panus, D. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. 92: 5545-5549.
7. Derynck, R. and Y. Zhang. 1996. Intracellular signaling: The Mad way to do it. Curr. Biol. 6: 1226-1229.
8. Derynck, R. and X.-H. Feng. 1997. TGF-β receptor signaling. Biochim. Biophy. Acta (Rev. Cancer) 1333: F105-F150.
9. Feng, X.-H. and R. Derynck. 1996. Ligand-independent activation of TGF-β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors. J. Biol. Chem. 271: 13123-13129.
10. Feng, X.-H. and R. Derynck. 1997. A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J. 16: 3912-3923.
11. Feng, X.-H., E.H. Filvaroff, and R. Derynck. 1995. TGF-β-induced downregulation of cyclin A expression requires a functional TGF-β receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 270: 24237-24245.
12. Goldman, P., V. Tran, and R.H. Goodman. 1997. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog. Hormone Res. 52: 103-119.
13. Goyette, M.C., K. Cho, C.L. Fasching, D.B. Levy, K.W. Kinzler, C. Paraskeva, B. Vogelstein, and E. Stanbridge. 1992. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12: 1387-1395.
14. Graycar, J.L., D.A. Miller, B.A. Arrick, R.M. Lyons, H.L. Moses, and R. Derynck. 1989. Human transforming growth factor-β 3: Recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2. Mol. Endocrinol. 3: 1977-1986.
15. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75: 791-803.
16. Hata, A., R. Lo, D. Wotton, G. Lagna, and J. Massagué. 1997. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 88: 82-87.
17. Heldin, C.-H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
18. Hoodless, P., T. Haerry, S. Abdollah, M. Stapleton, M.B. O'Connor, L. Attisano, and J.L. Wrana. 1996. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489-500.
19. Horvai, A., L. Xu, E. Korzus, G. Brard, D. Kalafus, T.-M. Mullen, D. Rose, M.G. Rosenfeld, and C.K. Glass. 1997. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. 94: 1074-1079.
20. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. Heyman, D. Rose, C. Glass, and M.G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
21. Keeton, M., S. Curriden, A.-J. van Zonneveld, and D.J. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266: 23048-23052.
22. Kim, J., K. Johnson, H. Chen, S. Carroll, and A. Laughon. 1997. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388: 304-308.
23. 125 product involves separate E1A domains. Mol. Cell. Biol. 12: 4391-4399.
24. Kretzschmar, M., F. Liu, A. Hata, J. Doody, and J. Massagué. 1997. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes & Dev. 11: 984-995.
25. Kwok, R., J. Lundblad, J. Chrivia, J. Richards, H. Bächinger, R. Brennan, S. Roberts, M. Green, and R.H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370: 223-226.
26. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué. 1996. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383: 832-836.
27. Lill, N., S. Grossman, D. Ginsberg, J. DeCaprio, and D.M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827.
28. Liu, F., A. Hata, J.C. Baker, J. Doody, J. Cárcamo, R.M. Harland, and J. Massagué. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623.
29. Macías-Silva, M., S. Abdollah, P. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR-2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
30. Massagué, J., A. Hata, and F. Liu. 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7: 187-192.
31. Nakao, A., T. Imamura, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J. Hanai, C.-H. Heldin, K. Miyazono, and P. ten Dijke. 1997. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16: 5353-5362.
32. Shi, Y., A. Hata, R. Lo, J. Massagué, and N. Pavletich. 1997. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388: 87-93.
33. Shikama, N., J. Lyon, and N. La Thangue. 1997. The p300/CBP family: Integrating signals with transcription factors and chromatin. Trends Cell Biol. 7: 230-236.
34. Silver, P., L. Keegan, and M. Ptashne. 1984. Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc. Natl. Acad. Sci. 81: 5951-5955.
35. 467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem. 272: 28107-28115.
36. Wrana, J.L. and L. Attisano. 1996. MAD-related proteins in TGF-β signalling. Trends Genet. 12: 493-496.
37. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347.
38. Wu, R.-Y., Y. Zhang, X.-H. Feng, and R. Derynck. 1997. Homomeric and heteromeric interactions are required for signaling activity and functional cooperativity of Smad-3 and -4. Mol. Cell. Biol. 17: 2521-2528.
39. Yingling, J., M. Datto, C. Wong, J. Frederick, N. Liberati, and X.-F. Wang. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17: 7019-7028.
40. Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383: 168-172.
41. Zhang, Y., T. Musci, and R. Derynck. 1997. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function: Cooperativity with other Smads and interference of a Smad4/DPC4 mutant with nuclear translocation of Smads. Curr. Biol. 7: 270-276.